價(jià)格 | 詢價(jià) |
包裝 | 1盒 |
最小起訂量 | 1盒 |
發(fā)貨地 | 上海 |
更新日期 | 2025-03-04 |
中文名稱:L-Histidinol (hydrochloride) | 英文名稱:L-Histidinol (hydrochloride) |
CAS:1596-64-1 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 1596-64-1 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號(hào) | 型號(hào) |
L-Histidinol (hydrochloride) | 500mg 1g 5g | 1596-64-1 | EY-Y0164298 |
Cas No.1596-64-1
別名 (S)-Histidinol
化學(xué)名 (βS)-amino-1H-imidazole-5-propanol, dihydrochloride
分子式 C6H11N3O ? 2HCl
分子量 214.1
溶解度 ≤5mg/ml in DMSO
儲(chǔ)存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
L-Histidinol is an intermediate in the biosynthesis of the amino acid L-histidine.
L-Histidine biosynthesis is a metabolic pathway present in bacteria, archaea, lower eukaryotes, as well as plants. L-histidine biosynthesis has been studied mainly in Escherichia coli and Salmonella typhimurium, revealing fundamental regulatory processes in bacteria.
In vitro: Preliminary experiments were done to investigate the cytotoxic effect of L-histidinol on cultured EAC cells. Results showed that L-histidinol up to 4 mM had no cytotoxic effects on EAC cells. Doxorubicin alone showed concentration-dependent cytotoxic effects. L-Histidinol combination with doxorubicin led to significant potentiation of doxorubicin cytotoxicity to EAC cells compared to doxorubicin alone. The concentration that caused 50% growth inhibition in EAC cells after 24 h incubation was about 0.2 μg/ml, whereas it was 0.1 μg/ml when L-histidinol was added to culture medium [1].
In vivo: L-Histidinol at 250 mg/kg for five consecutive doses before doxorubicin single injection could enhance the antitumour activity of doxorubicin in EAC-bearing mice as demonstrated by a significant increase in average life span and cure rate of mice. In normal mice, L-histidinol, in the same dose regimen, could not alter the acute cardiotoxicity and lethality of doxorubicin [1].
Clinical trial: So far, no clinical study has been conducted.
Reference:
[1] Al-Shabanah OA, Badary OA, Al-Gharably NM, Al-Sawaf HA. Effects of L-histidinol on the antitumour activity and acute cardiotoxicity of doxorubicin in mice. Pharmacol Res. 1998 Sep;38(3):225-30.
成立日期 | 2014-06-05 (11年) | 注冊(cè)資本 | 100 |
員工人數(shù) | 50-100人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥500 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-03-04 | |
¥415 |
VIP3年
|
TargetMol中國(陶術(shù)生物)
|
2025-02-28 | |
¥599.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2025-02-27 | |
詢價(jià) |
VIP1年
|
廣州佳途科技股份有限公司
|
2025-02-05 | |
¥720.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2025-01-20 | |
¥800 |
廣州市樂試生物科技有限公司
|
2023-04-16 | ||
¥180 |
阿勒山(廣州)生物科技有限公司
|
2022-02-17 |